Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Imatinib | 152459-95-5 | MFCD00868202 | C29H31N7O | 500 MG
Supplier: Medchemexpress LLC HY15463500MG
Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR, and c-kit kinase activity. It functions by binding near the ATP binding site, which locks the kinase in a closed or self-inhibited conformation, thereby semicompetitively inhibiting the enzyme activity of the protein. Additionally, Imatinib is an inhibitor of SARS-CoV and MERS-CoV.
- Selectively inhibits BCR/ABL, v-Abl, PDGFR, and c-kit kinase activity.
- Functions by binding near the ATP binding site.
- Inhibits enzyme activity of the protein semicompetitively.
- Inhibitor of SARS-CoV and MERS-CoV.
- For research use only.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?